![Terry Tougas, PhD](https://iqconsortium.org/images/uploads/TTougas.png)
TERRY TOUGAS, PhD
IQ Board of Directors Chair (2010-2012)
Highly Distinguished Research Fellow
Boehringer Ingelheim (Ret.)
|
![Lewis Kinter, PhD](https://iqconsortium.org/images/uploads/LKinter.png)
LEWIS KINTER, PhD, DABT, FATS
IQ Board of Directors Chair (2012-2014)
Senior Director, Regulatory Toxicology
AstraZeneca (Ret.)
|
![](https://iqconsortium.org/images/uploads/MFaul.jpg)
MARGARET FAUL, PhD
IQ Board of Directors Chair (2021-2023)
Vice President, Drug Product Technologies
Amgen
|
![Michael Garvin, PhD](https://iqconsortium.org/images/uploads/MGarvin.jpg)
MICHAEL GARVIN, PharmD
IQ Board of Directors Member(2014-Present)
Senior Director, Regulatory Policy
AstraZeneca
|
![Douglas Keller, PhD](https://iqconsortium.org/images/uploads/DKeller.jpg)
DOUG KELLER, PhD
IQ Board of Directors Member (2010-2020)
Global Head for Development Projects, Preclinical Safety
Sanofi (Ret.)
|
![Nancy Agrawal, PhD](https://iqconsortium.org/images/uploads/NAgrawal.jpg)
NANCY AGRAWAL, PhD
IQ Translational and ADME Sciences Leadership Group (2013-Present)
Vice President, Pharmacokinetics, Pharmacodynamics,
Drug Metabolism (PPDM)
Merck & Co., Inc.
|
![Akintunde](https://iqconsortium.org/images/uploads/TBello.jpg)
TUNDE BELLO, PhD
IQ Clinical Pharmacology Leadership Group (2012-Present)
Vice President, Clinical Pharmacology and Pharmacometrics
Bristol Myers Squibb
|
TIM WATSON, PhD
IQ Board of Directors Vice Chair (2021-2023)
Executive Director/Leader of the Global CMC Advisory Office
Pfizer
|
![](https://iqconsortium.org/images/uploads/SGirish.png)
SANDHYA GIRISH, PhD
IQ Clinical Pharmacology Leadership Group (CPLG) (2016-Present)
Vice President, Clinical Pharmacology
Gilead
|
![](https://iqconsortium.org/images/uploads/MGraziano.png)
MICHAEL GRAZIANO, PhD
IQ Board of Directors Member (2021-Present)
Associate Vice President, Preclinical Development
Organon LLC
|
![](https://iqconsortium.org/images/uploads/JBurkhardt.png)
JOHN BURKHARDT, PhD, DVM
IQ Board of Directors Member (2018-2021)
Senior Vice President - Global Head, Drug Safety R&D
Pfizer
|
![](https://iqconsortium.org/images/uploads/CMcMillian.png)
CARL McMILLIAN, PhD
IQ Board of Directors Chair (2018-2020)
Vice President, Toxicology, Drug Disposition, PKPD
Eli Lilly and Company
|
![](https://iqconsortium.org/images/uploads/TMonticello.png)
THOMAS MONTICELLO, PhD, DVM, DIPLOMATE OF ACVP
IQ Board of Directors Chair (2015-Present)
Executive Director
Amgen
![](https://iqconsortium.org/images/uploads/BTernik.png)
ROBERT TERNIK, PhD
IQ Drug Product Leadership Group (DPLG) (2012-Present)
Sr. Research Advisor and Design Team Leader
Eli Lilly and Company
|
![](https://iqconsortium.org/images/uploads/DOConnor_circle.png)
DENNIS O’CONNOR
IQ Consortium Board of Directors Member (2018-2021)
Senior Associate Director, GMP QA
Boehringer Ingelheim (Ret.)
![](https://iqconsortium.org/images/uploads/MLiu.png)
MAGGIE LIU, PhD
IQ DruSafe (2017-Present)
Director
Pfizer
|
![](https://iqconsortium.org/images/uploads/VSinha.jpg)
VIKRAM SINHA, PhD, FACP
IQ Clinical Pharmacology Leadership Group (CPLG) (2017-Present)
Vice President, Global Head Quantitative Clinical Pharmacology
Takeda
![](https://iqconsortium.org/images/uploads/TCurran.png)
TIMOTHY CURRAN, PhD
IQ Board of Directors Member (2019-Present)
Senior Director
Vertex
|
![](https://iqconsortium.org/images/uploads/DClemons.png)
DONNA CLEMONS, DVM, MS. DACLAM
IQ 3Rs Translational and Predictive Sciences Leadership Group (3Rs TPS) (2012-Present)
Global Director Comparative Medicine, AbbVie
|
|
|
|
|